Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bufalin, (3alpha,5beta)-isomer
1. 465-21-4
2. 3-beta,14-dihydroxy-5-beta-bufa-20,22-dienolide
3. 3,14-dihydroxy-bufa-20,22-dienolide
4. U549s98qlw
5. 5-((3s,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2h-pyran-2-one
6. Chebi:517248
7. 3beta,14beta-dihydroxy-5beta-bufa-20,22-dienolide
8. 5-[(3s,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
9. Unii-u549s98qlw
10. Nsc-89595
11. Ch'an Su
12. Buf
13. Nsc 89595
14. Brn 5141601
15. Bufalin [mi]
16. (3beta,5beta)-3,14-dihydroxybufa-20,22-dienolide
17. Bufalin [who-dd]
18. Schembl165666
19. Bufa-20,22-dienolide, 3,14-dihydroxy-, (3.beta.,5.beta.)-
20. Chembl399680
21. Bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-
22. Dtxsid90873563
23. Amy40632
24. Bufalin: Bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-,
25. Hy-n0877
26. Zinc4215121
27. Hsci1_000110
28. Lmst01130001
29. Mfcd30207876
30. S7821
31. Akos015965454
32. Cs-3694
33. Smp2_000290
34. Ac-20197
35. Ac-34068
36. Bs-17080
37. C16922
38. 5beta-bufa-20,22-dienolide, 3beta,14-dihydroxy-
39. Brd-k63606607-001-01-8
40. Brd-k63606607-001-02-6
41. Q18379323
42. 5-beta-bufa-20,22-dienolide, 3-beta,14-dihydroxy-
43. Bufa-20,22-dienolide, 3,14-dihydroxy-, (3beta,5beta)-
44. Bufa-20,22-dienolide, 3,14-dihydroxy-, (3-beta,5-beta)-
45. (3beta,5beta,10alpha,17alpha)-3,14-dihydroxybufa-20,22-dienolide
Molecular Weight | 386.5 g/mol |
---|---|
Molecular Formula | C24H34O4 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 386.24570956 g/mol |
Monoisotopic Mass | 386.24570956 g/mol |
Topological Polar Surface Area | 66.8 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 741 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
A Bufalin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bufalin, including repackagers and relabelers. The FDA regulates Bufalin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bufalin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bufalin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bufalin supplier is an individual or a company that provides Bufalin active pharmaceutical ingredient (API) or Bufalin finished formulations upon request. The Bufalin suppliers may include Bufalin API manufacturers, exporters, distributors and traders.
click here to find a list of Bufalin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Bufalin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bufalin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bufalin GMP manufacturer or Bufalin GMP API supplier for your needs.
A Bufalin CoA (Certificate of Analysis) is a formal document that attests to Bufalin's compliance with Bufalin specifications and serves as a tool for batch-level quality control.
Bufalin CoA mostly includes findings from lab analyses of a specific batch. For each Bufalin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bufalin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bufalin EP), Bufalin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bufalin USP).
LOOKING FOR A SUPPLIER?